Immune response with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Phase II ProACT study

被引：0

作者：

Gardner, Thomas A.

Petrylak, Daniel Peter

Corman, John M.

Hall, Simon

Weinstein, Ralph

Keyser, Robert

Sims, Robert Brownell

Sanders, Amanda

Sheikh, Nadeem A.

Higano, Celestia S.

机构：

[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA

[2] Columbia Univ, Med Ctr, New York, NY USA

[3] Virginia Mason Med Ctr, Seattle, WA 98101 USA

[4] Mt Sinai Sch Med, New York, NY USA

[5] US Oncol, Portland, OR USA

[6] Dendreon Corp, Seattle, WA USA

[7] Univ Washington, Sch Med, Seattle, WA USA

来源：

关键词：

D O I：

10.1200/jco.2013.31.6_suppl.148

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

148

引用

页数：1